Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Protein instability and immunogenicity: roadblocks to clinical application of injectable protein delivery systems for sustained release.

Jiskoot W, Randolph TW, Volkin DB, Middaugh CR, Schöneich C, Winter G, Friess W, Crommelin DJ, Carpenter JF.

J Pharm Sci. 2012 Mar;101(3):946-54. doi: 10.1002/jps.23018. Epub 2011 Dec 14.

PMID:
22170395
2.

Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems.

Schwendeman SP.

Crit Rev Ther Drug Carrier Syst. 2002;19(1):73-98. Review.

PMID:
12046892
3.

Improving protein therapeutics with sustained-release formulations.

Putney SD, Burke PA.

Nat Biotechnol. 1998 Feb;16(2):153-7. Review. Erratum in: Nat Biotechnol 1998 May;16(5):478.

PMID:
9487521
4.

Designer protein delivery: From natural to engineered affinity-controlled release systems.

Pakulska MM, Miersch S, Shoichet MS.

Science. 2016 Mar 18;351(6279):aac4750. doi: 10.1126/science.aac4750. Review.

PMID:
26989257
5.

Proprietary Rel-Ease drug delivery technology: opportunity for sustained delivery of peptides, proteins and small molecules.

Ye M, Bhat G, Johnston KA, Tan H, Garnick M.

Expert Opin Drug Deliv. 2006 Sep;3(5):663-75. Review.

PMID:
16948561
6.

Chitin/PLGA blend microspheres as a biodegradable drug delivery system: a new delivery system for protein.

Mi FL, Shyu SS, Lin YM, Wu YB, Peng CK, Tsai YH.

Biomaterials. 2003 Dec;24(27):5023-36.

PMID:
14559016
7.

Protein and peptide parenteral controlled delivery.

Pawar R, Ben-Ari A, Domb AJ.

Expert Opin Biol Ther. 2004 Aug;4(8):1203-12. Review.

PMID:
15268656
8.

Issues in long-term protein delivery using biodegradable microparticles.

Ye M, Kim S, Park K.

J Control Release. 2010 Sep 1;146(2):241-60. doi: 10.1016/j.jconrel.2010.05.011. Epub 2010 May 19.

PMID:
20493221
9.

Current advances in sustained-release systems for parenteral drug delivery.

Shi Y, Li LC.

Expert Opin Drug Deliv. 2005 Nov;2(6):1039-58. Review.

PMID:
16296808
10.

Development of biodegradable in situ implant and microparticle injectable formulations for sustained delivery of haloperidol.

Ahmed TA, Ibrahim HM, Ibrahim F, Samy AM, Kaseem A, Nutan MT, Hussain MD.

J Pharm Sci. 2012 Oct;101(10):3753-62. doi: 10.1002/jps.23250. Epub 2012 Jun 29.

PMID:
22753324
11.

Formulation strategies for sustained release of proteins.

Lewis AL, Illum L.

Ther Deliv. 2010 Sep;1(3):457-79. Review.

PMID:
22816145
12.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
13.

Injectable microsphere/hydrogel combination systems for localized protein delivery.

Lee J, Lee KY.

Macromol Biosci. 2009 Jul 7;9(7):671-6. doi: 10.1002/mabi.200800317.

PMID:
19226561
14.

Long-term delivery of protein therapeutics.

Vaishya R, Khurana V, Patel S, Mitra AK.

Expert Opin Drug Deliv. 2015 Mar;12(3):415-40. doi: 10.1517/17425247.2015.961420. Epub 2014 Sep 24. Review.

15.

Microsphere delivery of Risperidone as an alternative to combination therapy.

D'Souza S, Faraj J, DeLuca P.

Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):631-9. doi: 10.1016/j.ejpb.2013.07.012. Epub 2013 Jul 24.

PMID:
23892159
16.
17.

Trehalose limits BSA aggregation in spray-dried formulations at high temperatures: implications in preparing polymer implants for long-term protein delivery.

Rajagopal K, Wood J, Tran B, Patapoff TW, Nivaggioli T.

J Pharm Sci. 2013 Aug;102(8):2655-66. doi: 10.1002/jps.23634. Epub 2013 Jun 10.

PMID:
23754501
18.

Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system.

Amjadi I, Rabiee M, Hosseini MS, Mozafari M.

Appl Biochem Biotechnol. 2012 Nov;168(6):1434-47. doi: 10.1007/s12010-012-9868-4. Epub 2012 Sep 14.

PMID:
22976852
19.

Protein drug oral delivery: the recent progress.

Lee HJ.

Arch Pharm Res. 2002 Oct;25(5):572-84. Review.

PMID:
12433186
20.

PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.

Chan JM, Zhang L, Yuet KP, Liao G, Rhee JW, Langer R, Farokhzad OC.

Biomaterials. 2009 Mar;30(8):1627-34. doi: 10.1016/j.biomaterials.2008.12.013. Epub 2008 Dec 25.

PMID:
19111339

Supplemental Content

Support Center